BOD Science Ltd

AU:BOD Australia Drug Manufacturers - Specialty & Generic
Market Cap
$2.64 Million
AU$4.26 Million AUD
Market Cap Rank
#35289 Global
#1322 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.02
All Time High
AU$0.67
Categories
Companies in Australia Drug Manufacturers - Specialty & Generic Cannabis & CBD
About

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and dis… Read more

BOD Science Ltd - Asset Resilience Ratio

Latest as of December 2022: 64.00%

BOD Science Ltd (BOD) has an Asset Resilience Ratio of 64.00% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
AU$3.88 Million
Cash + Short-term Investments
Total Assets
AU$6.06 Million
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how BOD Science Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down BOD Science Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$3.88 Million 64.0%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$3.88 Million 64.00%

Asset Resilience Insights

  • Very High Liquidity: BOD Science Ltd maintains exceptional liquid asset reserves at 64.00% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

BOD Science Ltd Industry Peers by Asset Resilience Ratio

Compare BOD Science Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF 		Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA 		Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020 		Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 		Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100 		Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 		Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002 		Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227 		Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for BOD Science Ltd (None–None)

The table below shows the annual Asset Resilience Ratio data for BOD Science Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points